12-110493230-T-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_016226.5(VPS29):āc.197A>Gā(p.Asn66Ser) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0000254 in 1,496,914 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_016226.5 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VPS29 | NM_016226.5 | c.197A>G | p.Asn66Ser | missense_variant, splice_region_variant | 3/4 | ENST00000549578.6 | NP_057310.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VPS29 | ENST00000549578.6 | c.197A>G | p.Asn66Ser | missense_variant, splice_region_variant | 3/4 | 1 | NM_016226.5 | ENSP00000447058 | P3 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152146Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000852 AC: 14AN: 164328Hom.: 0 AF XY: 0.0000556 AC XY: 5AN XY: 89946
GnomAD4 exome AF: 0.0000201 AC: 27AN: 1344650Hom.: 0 Cov.: 28 AF XY: 0.0000167 AC XY: 11AN XY: 659990
GnomAD4 genome AF: 0.0000722 AC: 11AN: 152264Hom.: 0 Cov.: 31 AF XY: 0.0000403 AC XY: 3AN XY: 74460
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2021 | The c.209A>G (p.N70S) alteration is located in exon 4 (coding exon 4) of the VPS29 gene. This alteration results from a A to G substitution at nucleotide position 209, causing the asparagine (N) at amino acid position 70 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at